PetMed Express is a medical - pharmaceuticals company in the healthcare sector trading on NASDAQ, led by CEO Leslie C. G. Campbell, with a market cap of $49.4M.
Common questions about PetMed Express
PetMed Express is scheduled to report earnings for Q4 2026 on June 9, 2026. Analysts estimate revenue of $18.9M.
PetMed Express has approximately 287 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.